Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6751
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.63B
| $1.07M | ﹤0.01% |
14,113
-18,917
| -57% | -$1.56M |
|
6752
CALL
Loews
L
$23.1B
| $1.07M | ﹤0.01% |
18,100
+3,900
| +27% | +$245K |
|
6753
PUT
Power Integrations
POWI
$3.29B
| $1.07M | ﹤0.01% |
14,300
+7,600
| +113% | +$617K |
|
6754
ProShares Short Russell2000
RWM
$110M
| $1.07M | ﹤0.01% |
41,198
-3,315
| -7% | -$80.8K |
|
6755
CALL
Thomson Reuters
TRI
$44.1B
| $1.07M | ﹤0.01% |
9,775
-1,139
| -10% | -$121K |
|
6756
CALL
Viridian Therapeutics
VRDN
$2.69B
| $1.07M | ﹤0.01% |
+92,700
| New | +$1.25M |
|
|
CRON
6757
CALL
Cronos Group
CRON
$1.18B
| $1.07M | ﹤0.01% |
380,200
-172,900
| -31% | -$539K |
|
6758
HDFC Bank
HDB
$119B
| $1.07M | ﹤0.01% |
39,014
+20,792
| +114% | +$586K |
|
6759
PUT
iShares Gold Trust
IAU
$64.8B
| $1.07M | ﹤0.01% |
31,250
-11,650
| -27% | -$414K |
|
6760
Nuveen ESG Large-Cap ETF
NULC
$72.7M
| $1.07M | ﹤0.01% |
33,779
+2,918
| +9% | +$101K |
|
6761
CALL
Advanced Drainage Systems
WMS
$10.9B
| $1.07M | ﹤0.01% |
11,900
-400
| -3% | -$41.1K |
|
6762
CALL
Vanguard World Funds Extended Duration ETF
EDV
$3.42B
| $1.07M | ﹤0.01% |
10,700
+1,400
| +15% | +$146K |
|
6763
PUT
Warrior Met Coal
HCC
$5.15B
| $1.07M | ﹤0.01% |
35,000
+17,100
| +96% | +$592K |
|
6764
PIMCO RAFI ESG US ETF
RAFE
$169M
| $1.07M | ﹤0.01% |
38,908
-1,566
| -4% | -$46.1K |
|
|
BICK
6765
DELISTED
First Trust BICK Index Fund
BICK
| $1.07M | ﹤0.01% |
40,343
+32,312
| +402% | +$889K |
|
|
DAWN
6766
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.07M | ﹤0.01% |
59,804
-51,932
| -46% | -$536K |
|
6767
Alpha Architect International Quantitative Momentum ETF
IMOM
$159M
| $1.07M | ﹤0.01% |
+43,475
| New | +$1.18M |
|
6768
Textron
TXT
$15.1B
| $1.07M | ﹤0.01% |
17,516
-15,053
| -46% | -$988K |
|
6769
PUT
Jazz Pharmaceuticals
JAZZ
$16.5B
| $1.07M | ﹤0.01% |
6,848
-5,400
| -44% | -$831K |
|
6770
Omeros
OMER
$1.25B
| $1.07M | ﹤0.01% |
388,382
+141,566
| +57% | +$480K |
|
|
SPCK
6771
The SPAC and New Issue ETF
SPCK
$8.24M
| $1.07M | ﹤0.01% |
39,187
+28,895
| +281% | +$794K |
|
6772
PUT
Vanguard Total International Stock ETF
VXUS
$162B
| $1.07M | ﹤0.01% |
20,700
-17,800
| -46% | -$988K |
|
6773
FTC Solar
FTCI
$36M
| $1.07M | ﹤0.01% |
29,495
-21,315
| -42% | -$844K |
|
6774
PUT
Costamare
CMRE
$1.8B
| $1.07M | ﹤0.01% |
88,100
-13,900
| -14% | -$193K |
|
6775
CALL
Manulife Financial
MFC
$73.3B
| $1.07M | ﹤0.01% |
61,500
+6,400
| +12% | +$121K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.